Direct evidence to support the role of antigen-specific CD8+ T cells in melanoma-associated vitiligo

Journal of Investigative Dermatology

Volumn 117, Issue 6, 2001, Pages 1464-1470

  Le Gal, Frédérique Anne ^a   Avril, Marie Fran�oise ^b   Bosq, Jacques ^b   Lefebvre, Philippe ^a   Deschemin, Jean Christophe ^a   Andrieu, Muriel ^a   Dore, Martin Xavier ^b   Guillet, Jean Gérard ^a  

^a INSTITUT COCHIN   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Melanoma; Skin; T lymphocytes; Tumor immunity; Vitiligo

Indexed keywords

CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; MALE; MELANOCYTE; MELANOMA; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; VITILIGO;

EID: 0035674773     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01605.x     Document Type: Article

References (39)

1. An imunohistological study of cutaneous lymphocytes in vitiligo
2. Tyrosinase as an autoantigen in patients with vitiligo
3. Accumulation of identical T cells in melanoma and vitiligo-like leukoderma
4. CD4+ T-cell memory, CD45R subsets and the persistence of antigen - A unifying concept
5. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes
6. Vitiligo-like lesions in patients with melanoma treated with immunotherapy
7. Prognostic significance of hypopigmentation in malignant melanoma
8. Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes
9. Single-step method of RNA isolation by acid guanidinium thicyanate-phenol-chloroform extraction
10. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells
11. Identification of pigment cell antigens defined by vitiligo antibodies
12. An invariant Vα24-JαQ/Vβ11 T cell receptor is expressed in all individuals by clonally expanded CD4-8-T cells
13. TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture
14. Prolonged survival in metastatic malignant melanoma associated with vitiligo
15. Number of interleukin-4- and interferon-gamma-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: Distinct response profiles depending on the type of antigen used for activation
16. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells
17. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor infiltrating lymphocytes
18. Identification of gp100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells
19. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implication for tumor vacine development
20. More on cutaneous reactions to recombinant cytokine therapy
21. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance
22. Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly reactive antiretroviral therapy
23. Anti-tyrosinase antibodies in malignant melanoma
24. Antibodies to normal human melanocytes in vitiligo
25. Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma
26. Vitiligo: It is important
27. Vitiligo in patients with metastatic melanoma: A good prognostic sign
28. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
29. Improved induction of melanoma-reactive CTL with peptides from the melanoma-antigen gp100 modified at HLA*0201-binding sites
30. Cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression
31. Ex vivo IFN-γ secretion by circulating CD8 T lymphocytes: Implications of a novel approach for T cell monitoring in infectious and malignant diseases
32. Preferentiel usage of the T-cell repertoire by influenza virus hemaglutinin-specific human specific CD4+ T lymphocytes: In vitro life span of clonotypic cells
33. Vitiligo in patients with melanoma: Normal tissue antigens can be targets for cancer immunotherapy
34. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
35. Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from pMel-17/gp100
36. The role of tyrosinase in autoimmune vitiligo
37. Enhanced generation of specific tumor-reactive CTL in vitro by selected melan-A/MART-1 immunodominant peptide analogues
38. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
39. Melanocyte destruction after immunotherapy of melanoma: Direct evidence of T-cell-mediated vitiligo